Renaissance Technologies (RenTech)'s NGNE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 14,000 shares of Neurogene Inc. (NGNE) worth $288,400, representing 0.00% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 6 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in NGNE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 14,000 shares. Largest reduction occurred in Q3 2024, reducing 30,000 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Neurogene (NGNE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Neurogene (NGNE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +14,000 | New Buy | 14,000 | $20.60 |
| Q4 2024 | -22,807 | Sold Out | 0 | $0.00 |
| Q3 2024 | -30,000 | Reduce 56.81% | 22,807 | $41.96 |
| Q2 2024 | -5,900 | Reduce 10.05% | 52,807 | $36.39 |
| Q1 2024 | +8,513 | Add 16.96% | 58,707 | $50.90 |
| Q4 2023 | +50,194 | New Buy | 50,194 | $19.38 |
Renaissance Technologies (RenTech)'s Neurogene Investment FAQs
Renaissance Technologies (RenTech) first purchased Neurogene Inc. (NGNE) in Q4 2023, acquiring 50,194 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Neurogene Inc. (NGNE) for 6 quarters since Q4 2023.
Renaissance Technologies (RenTech)'s largest addition to Neurogene Inc. (NGNE) was in Q4 2023, adding 50,194 shares worth $973,000.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 14,000 shares of Neurogene Inc. (NGNE), valued at approximately $288,400.
As of the Q4 2025 filing, Neurogene Inc. (NGNE) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Neurogene Inc. (NGNE) was 58,707 shares, as reported at the end of Q1 2024.